Refractory Status Epilepticus Treatment: Quality and Efficacy of Coma Induction

CompletedOBSERVATIONAL
Enrollment

147

Participants

Timeline

Start Date

April 22, 2020

Primary Completion Date

August 15, 2021

Study Completion Date

August 3, 2022

Conditions
Status EpilepticusRefractory Status Epilepticus
Interventions
OTHER

Data collection

"collection of patient data~Data collection (demographics, prehospital management, duration of ICU and hospital stay, destination at discharge, date(s) of seizure(s), electroencephalographic (EEG) data, seizure history and etiology, number and duration of SE episodes, medication, types of SE according to the current guidelines from the International League of Epilepsy (ILAE), neuroimaging features, comorbidities, laboratory parameters, complications during and after SE , laboratory testing, vital signs, fluid balance) will be performed from the digital medical records, the electroencephalographic and microbiologic database of patients"

Trial Locations (1)

4031

Clinic for Intensive Care Medicine, University Hospital Basel, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT04333082 - Refractory Status Epilepticus Treatment: Quality and Efficacy of Coma Induction | Biotech Hunter | Biotech Hunter